Javascript must be enabled to continue!
Distribution of Glutaminase and Glutamine Synthetase Activities in the Human Gastrointestinal Tract
View through CrossRef
1. The activities of the two key enzymes involved in glutamine metabolism, glutaminase and glutamine synthetase, were measured in mucosal biopsies taken from different sites throughout the human gastrointestinal tract, from oesophagus to rectum.
2. The specific activity of glutamine synthetase was highest in the stomach (4.5 nmol glutamine formed per minute per mg of protein), but both small and large intestine and the oesophagus had little synthesizing capacity (less than 0.3 nmol of glutamine formed per minute per mg of protein).
3. Glutaminase specific activity was highest in the small intestine (53 nmol glutamate formed per minute per mg of protein by duodenal mucosa), intermediate in the large intestine and lowest in the oesophagus and stomach (less than 13 nmol of glutamate formed per minute per mg of protein).
4. The glutamine concentration in the mucosa was lower in the duodenum than in the colon (0.62 and 0.95 mmol/kg wet weight respectively), but both were much lower than the measured Km values of glutaminases obtained from these sites (3.8 and 4.0 mmol/kg wet weight respectively).
5. The concentration of glutamine in saliva, stomach juice, bile and duodenal juice suggests that very little glutamine passes into the gastrointestinal tract via these secretions.
6. The study provides the most complete information on the distribution of glutamine synthetase and glutaminase along the human gastrointestinal tract, and suggests that (i) both the small and large intestines have a high potential for glutamine metabolism, but little synthesizing capacity, thus both must derive their glutamine from other sources, and (ii) neither the stomach nor the oesophagus have a high glutaminase activity, although the stomach has substantial capacity to synthesize glutamine. The distribution of the enzymes along the gastrointestinal tract may help rationalize the use of glutamine for treating diseases that affect different parts of the gastrointestinal tract.
Title: Distribution of Glutaminase and Glutamine Synthetase Activities in the Human Gastrointestinal Tract
Description:
1.
The activities of the two key enzymes involved in glutamine metabolism, glutaminase and glutamine synthetase, were measured in mucosal biopsies taken from different sites throughout the human gastrointestinal tract, from oesophagus to rectum.
2.
The specific activity of glutamine synthetase was highest in the stomach (4.
5 nmol glutamine formed per minute per mg of protein), but both small and large intestine and the oesophagus had little synthesizing capacity (less than 0.
3 nmol of glutamine formed per minute per mg of protein).
3.
Glutaminase specific activity was highest in the small intestine (53 nmol glutamate formed per minute per mg of protein by duodenal mucosa), intermediate in the large intestine and lowest in the oesophagus and stomach (less than 13 nmol of glutamate formed per minute per mg of protein).
4.
The glutamine concentration in the mucosa was lower in the duodenum than in the colon (0.
62 and 0.
95 mmol/kg wet weight respectively), but both were much lower than the measured Km values of glutaminases obtained from these sites (3.
8 and 4.
0 mmol/kg wet weight respectively).
5.
The concentration of glutamine in saliva, stomach juice, bile and duodenal juice suggests that very little glutamine passes into the gastrointestinal tract via these secretions.
6.
The study provides the most complete information on the distribution of glutamine synthetase and glutaminase along the human gastrointestinal tract, and suggests that (i) both the small and large intestines have a high potential for glutamine metabolism, but little synthesizing capacity, thus both must derive their glutamine from other sources, and (ii) neither the stomach nor the oesophagus have a high glutaminase activity, although the stomach has substantial capacity to synthesize glutamine.
The distribution of the enzymes along the gastrointestinal tract may help rationalize the use of glutamine for treating diseases that affect different parts of the gastrointestinal tract.
Related Results
Étude du métabolisme de la glutamine dans les leucémies aiguës myéloïdes
Étude du métabolisme de la glutamine dans les leucémies aiguës myéloïdes
La survie des cellules cancéreuses dépend d’une activité énergétique et biosynthétique accrue et la glutamine participe à de nombreux processus nécessaires à cette adaptation métab...
Rat hepatic glutaminase: identification of the full coding sequence and characterization of a functional promoter
Rat hepatic glutaminase: identification of the full coding sequence and characterization of a functional promoter
Glutamine catabolism in mammalian liver is catalysed by a unique isoenzyme of phosphate-activated glutaminase. The full coding and 5′ untranslated sequence for rat hepatic glutamin...
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract
Medulloblastoma is the most common malignant brain tumor in children. Currently, treatment consists of surgical resection, chemotherapy, and whole brain and...
Abstract 985: Mitochondrial glutamine fermentation enhances ATP synthesis in murine glioblastoma cells
Abstract 985: Mitochondrial glutamine fermentation enhances ATP synthesis in murine glioblastoma cells
Abstract
Otto Warburg first proposed that all cancer cells arise from irreversible impairment of respiration, thus requiring glucose fermentation as a compensatory e...
Glutamine availability regulates cDC subsets in tissue
Glutamine availability regulates cDC subsets in tissue
Abstract
Proliferating tumor cells take up glutamine for anabolic processes engendering glutamine deficiency in the tumor microenvironment. How thi...
Abstract 3090: Targeting glutamine metabolism as a therapeutic strategy in MYC-driven medulloblastoma
Abstract 3090: Targeting glutamine metabolism as a therapeutic strategy in MYC-driven medulloblastoma
Abstract
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Currently, treatment consists of surgical resection, chemotherapy, craniospinal rad...
Targeting Glutamine Metabolism in Myeloproliferative Neoplasms
Targeting Glutamine Metabolism in Myeloproliferative Neoplasms
Abstract
Introduction:
The chronic Philadelphia chromosome negative myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential t...
RHOJ Derived Peptide Promotes Chemosensitivity by Inhibiting Glutamine Metabolism in Gastric Cancer
RHOJ Derived Peptide Promotes Chemosensitivity by Inhibiting Glutamine Metabolism in Gastric Cancer
Abstract
Background
Chemoresistance is a cause of the failure of chemotherapy in gastric cancer (GC) treatment. Recent studies ...

